Cardlytics (CDLX) Tops Q4 EPS by 37c

Cardlytics (NASDAQ: CDLX) reported Q4 EPS of ($0.05), $0.37 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $90 million versus the consensus estimate of $76.58 million.

For earnings history and earnings-related data on Cardlytics (CDLX) click here.

You May Also Be Interested In

• Fox upgraded to overweight as Roku deal, ad strength lift outlook
• DeFi Technologies Inc. (DEFT) Reports Q2 Loss of $0.04
• Calamp Corp. (CAMP) Misses Q2 EPS by 33c